KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Opko Health (OPK) Leases (2019 - 2026)

Opko Health filings provide 10 years of Leases readings, the most recent being $45.8 million for Q1 2026.

  • On a quarterly basis, Leases fell 4.22% to $45.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was $45.8 million, a 4.22% decrease, with the full-year FY2025 number at $46.9 million, down 13.1% from a year prior.
  • Leases hit $45.8 million in Q1 2026 for Opko Health, down from $46.9 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $68.1 million in Q4 2023 to a low of $34.9 million in Q2 2023.
  • Median Leases over the past 5 years was $45.8 million (2026), compared with a mean of $48.4 million.
  • Biggest five-year swings in Leases: skyrocketed 867.89% in 2022 and later fell 27.27% in 2025.
  • Opko Health's Leases stood at $38.7 million in 2022, then soared by 75.82% to $68.1 million in 2023, then decreased by 20.69% to $54.0 million in 2024, then decreased by 13.1% to $46.9 million in 2025, then dropped by 2.41% to $45.8 million in 2026.
  • The last three reported values for Leases were $45.8 million (Q1 2026), $46.9 million (Q4 2025), and $45.7 million (Q3 2025) per Business Quant data.